文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

常染色体显性阿尔茨海默病的认知结局:来自携带有早老素-1 E280A 突变的哥伦比亚家系的综合综述。

Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.

机构信息

Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA.

Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

J Alzheimers Dis. 2024;101(2):397-415. doi: 10.3233/JAD-240360.


DOI:10.3233/JAD-240360
PMID:39213071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11616039/
Abstract

BACKGROUND: The largest identified kindred worldwide with a single mutation causing autosomal-dominant Alzheimer's disease (ADAD) is a family from Antioquia, Colombia, carrying the Presenilin-1 (PSEN1) E280A (Paisa) mutation. The majority of mutation carriers develop dementia, typically commencing in their late 30 s, with a median onset age of 49 years. Cognitive decline is a hallmark feature. OBJECTIVE: This review synthesizes the existing literature on neuropsychological assessments in PSEN1 E280A mutation carriers throughout their lifespan. We provide a comprehensive overview of cognitive outcomes in this unique population. METHODS: We reviewed and integrated the published research, analyzing studies on neuropsychological assessments in PSEN1 E280A carriers. Our focus was on measures of verbal, semantic, episodic, and spatial memory, and encompassed other cognitive domains such as language, attention, visuospatial memory, and executive functioning. RESULTS: Verbal, semantic, episodic, and spatial memory emerged as the most sensitive indicators of preclinical changes in PSEN1 E280A carriers. Inconsistencies were noted in findings from tests assessing language, attention, visuospatial memory, and executive functioning, suggesting potential limitations in detecting early cognitive changes in PSEN1 mutation carriers. Specific cognitive tasks developed for this population proved effective but underutilized. CONCLUSIONS: The review underscores the importance of continued test development tailored to detect early cognitive changes in PSEN1 E280A carriers, potentially enhancing ADAD screening. Furthermore, investigating ADAD mutations in children may identify early changes in AD and enhance our understanding of neuropsychological functioning across the lifespan. This synthesis provides valuable insights for researchers, clinicians, and policymakers engaged in the study and management of ADAD.

摘要

背景:全球范围内,携带单一突变导致常染色体显性阿尔茨海默病(ADAD)的最大家族是来自哥伦比亚安蒂奥基亚的一个家族,携带早老素-1(PSEN1)E280A(Paisa)突变。大多数突变携带者会发展为痴呆症,通常在 30 多岁开始发病,中位发病年龄为 49 岁。认知能力下降是其主要特征之一。

目的:本综述综合了 PSEN1 E280A 突变携带者在整个生命周期中的神经心理学评估的现有文献。我们全面概述了这一独特人群的认知结果。

方法:我们对已发表的研究进行了回顾和整合,分析了 PSEN1 E280A 携带者的神经心理学评估研究。我们的重点是言语、语义、情景和空间记忆等认知领域的测量,还包括语言、注意力、视空间记忆和执行功能等其他认知领域。

结果:言语、语义、情景和空间记忆是 PSEN1 E280A 携带者出现临床前变化的最敏感指标。评估语言、注意力、视空间记忆和执行功能的测试结果存在不一致,表明在检测 PSEN1 突变携带者的早期认知变化方面存在潜在局限性。针对该人群开发的特定认知任务虽然有效,但使用不足。

结论:本综述强调了继续开发针对 PSEN1 E280A 携带者的特定认知测试的重要性,这可能有助于 ADAD 的筛查。此外,对 AD 儿童的 AD 突变进行研究可能会发现 AD 的早期变化,并增强我们对整个生命周期中神经心理学功能的理解。本综述为从事 ADAD 研究和管理的研究人员、临床医生和政策制定者提供了有价值的见解。

相似文献

[1]
Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.

J Alzheimers Dis. 2024

[2]
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

Lancet Neurol. 2012-11-6

[3]
A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.

J Alzheimers Dis. 2018

[4]
Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.

Alzheimers Res Ther. 2024-10-1

[5]
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

J Clin Psychiatry. 2014-6

[6]
Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease.

N Engl J Med. 2024-6-20

[7]
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.

Lancet Neurol. 2012-11-6

[8]
Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.

J Alzheimers Dis. 2017

[9]
Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms.

JAMA Ophthalmol. 2021-1-1

[10]
Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.

J Int Neuropsychol Soc. 2017-3

引用本文的文献

[1]
Religious stress coping is associated with lower entorhinal tau pathology and better memory performance in autosomal dominant Alzheimer's disease.

J Alzheimers Dis. 2025-6

本文引用的文献

[1]
The MAPP Room Memory Test: Examining Contextual Memory Using a Novel Computerized Test in Cognitively-Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.

J Prev Alzheimers Dis. 2024

[2]
Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.

Nat Med. 2023-5

[3]
Associations of category fluency clustering performance with brain pathology in autosomal dominant Alzheimer's disease.

J Int Neuropsychol Soc. 2024-1

[4]
Memory for Semantically Related Objects Differentiates Cognitively Unimpaired Autosomal Dominant Mutation Carriers from Non-Carrier Family Members.

J Prev Alzheimers Dis. 2023

[5]
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.

Alzheimers Dement. 2022-11

[6]
Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort.

JAMA Netw Open. 2021-8-2

[7]
Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.

J Alzheimers Dis. 2021

[8]
Subjective Cognitive Decline and its Relation to Verbal Memory and Sex in Cognitively Unimpaired Individuals from a Colombian Cohort with Autosomal-Dominant Alzheimer's Disease.

J Int Neuropsychol Soc. 2022-7

[9]
Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.

Alzheimers Dement. 2021-5

[10]
Reaction time and response inhibition in autosomal dominant Alzheimer's disease.

Brain Cogn. 2021-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索